Gainers
- Avenue Therapeutics, Inc. ATXI shares surged 159.9% to $9.15. Avenue Therapeutics recently received the official meeting minutes from the FDA regarding a meeting conducted for IV Tramadol in combination with other opioid analgesics to manage moderate-to-moderately severe pain. Concurrently, Avenue Therapeutics announced that it would effect a 1-for-15 reverse stock split.
- PaxMedica, Inc. PXMD jumped 53.5% to $3.33 as the company issued a corporate update after IPO. The company named Stephen D. Sheldon as CFO.
- Scienjoy Holding Corporation SJ surged 33.4% to $2.2281 after declining 44% on Monday.
- InMed Pharmaceuticals Inc. INM gained 28% to $6.54. InMed recently reported a FY22 net loss of $33.17 per share.
- Bellerophon Therapeutics, Inc. BLPH jumped 24% to $1.2001. Bellerophon announced FDA acceptance of change to ongoing Phase 3 REBUILD study of INOpulse for the treatment of fibrotic interstitial lung disease.
- FingerMotion, Inc. FNGR gained 23% to $0.9999 after rising around 20% on Monday.
- Intelligent Living Application Group Inc. ILAG rose 21.6% to $2.48 after gaining over 11% on Monday.
- Grove Collaborative Holdings, Inc. GROV shares climbed 21.3% to $3.5901. Grove Collaborative continued retail expansion with entry into thousands of more stores.
- Unico American Corporation UNAM gained 20.8% to $1.5099.
- 9 Meters Biopharma, Inc. NMTR rose 20.3% to $0.2490 after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA for Vurolenatide in short bowel syndrome.
- Milestone Scientific Inc. MLSS gained 20% to $0.8193.
- Avalon GloboCare Corp. AVCO jumped 19.8% to $0.5271.
- Pyxis Oncology, Inc. PYXS gained 19.8% to $2.30.
- Biocept, Inc. BIOC gained 17.1% to $0.9368.
- Equillium, Inc. EQ jumped 15.5% to $2.23. Equillium announced interim results from the Type B portion of the EQUALISE study evaluating itolizumab in patients with lupus nephritis (LN).
- Foghorn Therapeutics Inc. FHTX rose 14.1% to $8.67.
- The Beauty Health Company SKIN gained 12.6% to $11.71 after the company announced a $200 million buyback.
- Stryve Foods, Inc. SNAX jumped 12% to $0.45.
- Skillz Inc. SKLZ jumped 11.9% to $1.0750.
- Verve Therapeutics, Inc. VERV gained 11.5% to $34.73.
- BitNile Holdings, Inc. NILE rose 10.6% to $0.2047.
- CVR Energy, Inc. CVI gained 8.2% to $27.65.
- BIT Mining Limited BTCM rose 7.7% to $0.28 after declining around 9% on Monday.
- Novavax, Inc. NVAX gained 7.5% to $20.28. Novavax announced an initial one million doses of Nuvaxovid are available for use in the UK.
Losers
- FedNat Holding Company FNHC fell 19.9% to $0.18 after dropping over 15% on Monday.
- Eve Holding, Inc. EVEX dropped 18% to $10.08. BLADE India signed non-binding order for up to 200 eVTOL vehicles from Eve Air Mobility.
- Polar Power, Inc. POLA fell 15.2% to $2.68 after gaining around 25% on Monday.
- Avidity Biosciences, Inc. RNA shares fell 14.9% to $15.95. The FDA has placed a partial clinical hold on new participant enrollment in Avidity Biosciences’ Phase 1/2 MARINA trial of AOC 1001 in adults with myotonic dystrophy type 1 (DM1).
- Evaxion Biotech A/S EVAX fell 14.9% to $2.34. Evaxion Biotech recently announced it reached an important milestone announcing today that it had enrolled its first patient in the global phase 2b clinical trial of EVX-01.
- FaZe Holdings Inc. FAZE dropped 14.2% to $12.66.
- Kiora Pharmaceuticals, Inc. KPRX shares fell 14.1% to $6.15. Kiora Pharmaceuticals said its stockholders authorized a reverse stock split of its common stock.
- SAI.TECH Global Corporation SAI dropped 14.1% to $4.10.
- Midatech Pharma plc MTP fell 14% to $2.2365.
- Minerva Surgical, Inc. UTRS dipped 13.8% to $0.7320.
- Provident Financial Services, Inc. PFS fell 12.5% to $20.27. Provident Financial Services and Lakeland Bancorp to merge in an all-stock transaction.
- 374Water, Inc. SCWO dropped 12.1% to $3.03.
- Golden Sun Education Group Limited GSUN fell 11.6% to $36.00.
- Kronos Worldwide, Inc. KRO dropped 11.2% to $9.48. Barclays maintained Kronos Worldwide with an Underweight and lowered the price target from $15 to $8.
- Inpixon INPX fell 10.4% to $0.1260. Inpixon shares jumped over 21% on Monday after the company announced it signed a definitive merger agreement with KINS Technology for KINS to acquire Inpixon's enterprise apps business.
- Ocular Therapeutix, Inc. OCUL dropped 10.5% to $4.7250. Ocular Therapeutix announced interim 7-month data from its U.S. Phase 1 trial evaluating OTX-TKI for wet age-related macular degeneration (wet AMD) and other retinal diseases.
- AMTD Digital Inc. HKD shares fell 8.9% to $59.22.
- Troika Media Group, Inc. TRKA shares fell 8.5% to $0.3453 after declining 6% on Monday.
- HeartCore Enterprises, Inc. HTCR dropped 7.9% to $1.05.
- Studio City International Holdings Limited MSC fell 6.9% to $2.28.
BLPHBellerophon Therapeutics Inc Com (New)
$0.0120-%
BTCMBIT Mining Ltd
$2.961.22%
CVICVR Energy Inc
$20.69-2.77%
EQEquillium Inc
$0.68002.13%
EVAXEvaxion Biotech AS
$6.2070.3%
EVEXEve Holding Inc
$4.923.80%
FHTXFoghorn Therapeutics Inc
$4.08-6.85%
FNGRFingerMotion Inc
$1.3413.6%
GROVGrove Collaborative Holdings Inc
$1.44-0.69%
GSUNGolden Sun Health Technology Group Ltd
$2.995.28%
HKDAMTD Digital Inc
$2.73-%
HTCRHeartCore Enterprises Inc
$1.59-0.04%
ILAGIntelligent Living Application Group Inc
$0.86001.42%
INMInMed Pharmaceuticals Inc
$4.09-2.68%
KPRXKiora Pharmaceuticals Inc
$3.892.37%
KROKronos Worldwide Inc
$9.92-1.10%
MLSSMilestone Scientific Inc
$1.386.15%
MSCStudio City International Holdings Ltd
$5.1513.2%
NVAXNovavax Inc
$9.23-3.35%
OCULOcular Therapeutix Inc
$8.152.13%
PFSProvident Financial Services Inc
$18.96-0.05%
POLAPolar Power Inc
$3.202.89%
PXMDPaxMedica Inc
$0.0310-95.5%
PYXSPyxis Oncology Inc
$1.58-3.66%
RNAAvidity Biosciences Inc
$29.67-1.53%
SCWO374Water Inc
$0.58011.54%
SJScienjoy Holding Corp
$0.8507-5.48%
SKINThe Beauty Health Co
$1.732.37%
SKLZSkillz Inc
$6.531.08%
SNAXStryve Foods Inc
$0.77010.93%
UNAMUnico American Corp
$0.0700-%
UTRSMinerva Surgical Inc
$0.000001-%
VERVVerve Therapeutics Inc
$7.95-0.50%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in